Settings

Design

If you use one of the color modes, the TUM website and its elements will be displayed in either dark or light.

The settings are stored on your computer and not transferred to the server.
  • 3/10/2020
  • Reading time 2 min.

Mutations in plasma cells play a key role in light chain amyloidosis

Fatal overproduction of antibodies

Bone marrow plasma cells produce antibodies. These comprise two long and two short protein chains. The pathological proliferation of plasma cells can lead to an overproduction of the short chains. These associate to fibrils and deposit in organs. The result is fatal organ failure. A research team from the Technical University of Munich (TUM) and Heidelberg University has now identified the mutation behind the disease in a patient.

PhD student Pamina Kazman examines the folding and stability of antibody domains with the circular dichroism spectrometer of the Chair of Biotechnology. A. Heddergott / TUM
PhD student Pamina Kazman examines the folding and stability of antibody domains with the circular dichroism spectrometer of the Chair of Biotechnology.

Antibodies are vital for the survival of human beings. They typically consist of two longer and thus heavier amino acid chains and two lighter ones. In rare cases, the plasma cells multiply excessively, flooding the body with light antibody chains.

In people suffering from light chain amyloidosis (AL amyloidosis), these light chains are deposited as extremely fine fibers, so-called amyloid fibrils, in tissue or in organs. The disease is often recognized only after the deposits already compromise the function of organs. In many cases AL amyloidosis is fatal.

"To date, little was known about the exact cause of this amyloidosis," says Johannes Buchner, professor of biotechnology at the Technical University of Munich. “Depending on the organ affected, the symptoms vary considerably. Furthermore, each patient produces different types of antibodies. The disease is thus difficult to diagnose at an early stage.”

A mutation triggers the deadly disease

Using various analytical and database-supported methods, the team of scientists succeeded in identifying eleven mutations caused by the disease in the antibodies of a patient with advanced AL amyloidosis.

Further investigations showed that exactly one mutation was responsible for the destabilization and formation of the disease-causing amyloid fibrils. This mutation causes the unstable light chain to lose its structure after breaking into fragments, which then form the deadly amyloid fibrils.

"Our study shows that mutations that lead to unstable light chains are an important factor in the occurrence of amyloidosis," says Pamina Kazman, who carried out the majority of the measurements. "In the long term, we hope that these and other studies will lead to new, earlier diagnostic methods and possibly even new treatment options."

Compared to the normal antibody fragment (left), that of the patient (right) has a significantly larger hydrophobic area (red). Due to its lower stability, this fragment can form the dangerous amyloid fibrils. P. Kazman / TUM
Compared to the normal antibody fragment (left), that of the patient (right) has a significantly larger hydrophobic area (red). Due to its lower stability, this fragment can form the dangerous amyloid fibrils.
Publications

Fatal amyloid formation in a patient’s antibody light chain is caused by a single point mutation
Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, Lioba Hunziger, Benedikt Weber, Ute Hegenbart, Martin Zacharias, Rolf Köhler, Stefan Schönland, Michael Groll, Johannes Buchner
eLife, online: 10.03.2020

Further information and links

The research was funded by the German Research Foundation (DFG). The protein structures were determined at the synchrotron radiation sources of the Paul Scherrer Institute in Villigen (Switzerland) and the European synchrotron radiation source in Grenoble (France).

High resolution images

Technical University of Munich

Corporate Communications Center

Contacts to this article:

Prof. Dr. Johannes Buchner
Professorship of Biotechnology
Technical University of Munich
Lichtenbergstr. 4, 85748 Garching, Germany
Tel.: +49 89 289 13340 – johannes.buchnerspam prevention@tum.de

Back to list

News about the topic

Human αA-crystallin forms structures of 12, 16 and 20 subunits (from left to right). Two subunits (center, dark and light gray) form a dimer.
  • Reading time 3 min.

Protective protein in the eye lens affects protein oxidation

Guardian angel of the eye

  • Research
[Translate to en:]
  • Reading time 4 min.

How molecular escorts help prevent cancer

Chaperones keep the tumor suppressor protein p53 in check

  • Research
Space-filling model of alphaB crystallin. The hexameric subunit is indicated in color – Image: Andi Mainz / TUM

Small heat shock protein as model for Alzheimer medication

New field of application for versatile helper

  • Research
Prefabrication principles: One of the three forms of the protein complex Sip1 is built-up by 32 identical subunits – Image: Tilly Fleckenstein / TUM

Regulation of an embryonic small heat shock protein deciphered

A protein provides emergency aid

  • Research
Structural model of the IgNAR shark antibody – Image: Janosch Hennig, TUM/Helmholtz Zentrum

Shark antibodies inspire optimization of human antibodies

Learning from sharks

  • Research
Storage form (24-mer) and active forms of αB-crystallin which protect against cataract

Activation mechanism of a protective protein in the ocular lens resolved

A protein safeguards against cataracts

  • Research
HSTS